Mending a broken heart: In vitro, in vivo and in silico models of congenital heart disease
Birth defects contribute to ∼0.3% of global infant mortality in the first month of life, and congenital heart disease (CHD) is the most common birth defect among newborns worldwide. Despite the significant impact on human health, most treatments available for this heterogenous group of disorders are...
Main Authors: | Abdul Jalil Rufaihah, Ching Kit Chen, Choon Hwai Yap, Citra N. Z. Mattar |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2021-03-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/14/3/dmm047522 |
Similar Items
-
The Role of Epigenetics in Congenital Heart Disease
by: Tingsen Benson Lim, et al.
Published: (2021-03-01) -
Geterogenety walls of heart on stages of early human cardiogenesis.
by: Kozlov S.V., et al.
Published: (2007-01-01) -
NKX2-5 mutations causative for congenital heart disease retain functionality and are directed to hundreds of targets
by: Romaric Bouveret, et al.
Published: (2015-07-01) -
Many ways to break a heart
by: Megan Rowton, et al.
Published: (2015-08-01) -
Maternal Pre-Existing Diabetes: A Non-Inherited Risk Factor for Congenital Cardiopathies
by: Stéphanie Ibrahim, et al.
Published: (2023-11-01)